Can Endometrial Cancer Cause Elevated WBC and Neutrophil Counts?
Yes, endometrial cancer can cause elevated white blood cell (WBC) and absolute neutrophil counts, and these elevations are associated with more advanced disease and worse prognosis.
Evidence for the Association
Multiple research studies demonstrate a clear relationship between elevated inflammatory markers and endometrial cancer:
Elevated WBC counts are significantly higher in endometrial cancer patients compared to those with benign pathology. In a study of 161 patients with abnormal uterine bleeding, WBC counts were significantly elevated in cancer patients versus those with hyperplasia (p=0.005) 1. Another study of surgically treated endometrial cancer patients found that elevated WBC count at diagnosis was an independent prognostic factor (HR=2.79,95% CI 1.50-4.96, p=0.0017) 2.
Neutrophil counts specifically are elevated in endometrial cancer. Research shows neutrophil counts are significantly higher in cancer patients compared to controls, and elevated neutrophil count at diagnosis is an independent predictor of survival (HR=2.76,95% CI 1.43-5.03, p=0.0033) 2. The neutrophil-to-lymphocyte ratio (NLR) is also significantly elevated in endometrial cancer patients compared to controls (MD 0.73,95% CI 0.01,1.45) 3.
Clinical Significance and Interpretation
What These Elevations Mean:
Advanced disease correlation: Elevated neutrophil counts are associated with advanced clinical stage (p<0.0001), lymphovascular space involvement (p=0.0003), and cervical involvement (p=0.0049) 2
Prognostic value: Higher WBC and neutrophil counts at diagnosis predict worse overall survival and treatment failure 2
Inflammatory response: These elevations reflect the systemic inflammatory response associated with malignancy 1, 4
Important Caveats:
These markers are not diagnostic tools. While elevated WBC and neutrophil counts are associated with endometrial cancer, they cannot distinguish between cancer and benign conditions with sufficient accuracy for diagnosis. The platelet-to-lymphocyte ratio (PLR) may help differentiate pathologic conditions from normal endometrium, but cannot reliably distinguish hyperplasia from cancer 1.
The elevations are typically modest. In hospitalized patients without infection, malignancy, or immune dysfunction, the normal WBC range extends to 14.5 × 10⁹/L 5, so values between 11-14.5 may not be abnormal in the hospital setting.
Diagnostic Approach for Your Patient
Given a patient with thickened endometrium, ongoing uterine bleeding, and elevated WBC/neutrophil counts:
Proceed with tissue diagnosis immediately - The guidelines are clear that abnormal uterine bleeding requires endometrial sampling regardless of inflammatory markers 6, 7, 6
Use transvaginal ultrasound first - Measure endometrial thickness with a cut-off of ≤3 mm to guide further workup 6
Obtain endometrial biopsy - Use Pipelle or Vabra devices (sensitivity 99.6% and 97.1% respectively) 6, 7
Consider hysteroscopy with biopsy if initial sampling is non-diagnostic or if focal pathology is suspected 6
Do not rely on inflammatory markers alone - The elevated WBC/neutrophil counts support concern for malignancy but cannot substitute for histologic diagnosis
The elevated inflammatory markers in your patient should heighten suspicion for endometrial cancer and potentially more advanced disease, but tissue diagnosis remains mandatory. Most endometrial cancers (90%) present with abnormal bleeding and are diagnosed at early stages 6, 8, 7, 6, so prompt endometrial sampling is the appropriate next step regardless of blood counts.